Aktis Oncology Inc.
AKTS | NASDAQ
$14.47
-$1.46 (-9.17%)
Nov 2, 2026, 10:41 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 82.49M | 371.63M | 37.78M | 180.25M | 37.16M | 224.64M |
Short-Term Investments | 434.83M | 166.85M | 189M | 65.97M | 260.01M | 87.77M |
Long-Term Investments | 1.15M | 1.15M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 3.71M | 3.6M | 7.33M | 5.32M | 4.46M | 2.29M |
Receivables | 2.3M | 2.2M | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.92M | 3.26M | 3.52M | 3.2M | 3.69M | 3M |
Total Current Assets | 524.54M | 543.94M | 230.31M | 249.42M | 300.85M | 315.41M |
Property-Plant & Equipment | 28.2M | 28.11M | 27.25M | 24.3M | 20.87M | 19.39M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 33.06M | 32.86M | 34.58M | 29.62M | 25.33M | 21.68M |
Total Assets | 557.6M | 576.8M | 264.89M | 279.04M | 326.18M | 337.09M |
Account Payables | 2.53M | 1.23M | 1.74M | 2.36M | 1.92M | 702K |
Deferred Revenue | 17.34M | 18.96M | 18.66M | 16.08M | 9.28M | 8.73M |
Short-Term Debt | 1.48M | 1.43M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.19M | 5.05M | 4.56M | 2.82M | 3.08M | 1.86M |
Total Current Liabilities | 32.13M | 27.91M | 31.24M | 26.91M | 18.82M | 17.01M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 333.41M | 333.41M | 333.41M | 333.42M |
Total Long-Term Liabilities | 40.63M | 42.78M | 379.8M | 384.52M | 395.16M | 396.87M |
Total Liabilities | 72.76M | 70.69M | 411.03M | 411.43M | 413.98M | 413.87M |
Total Debt | 11.24M | 11.58M | 11.55M | 11.87M | 12.01M | 12.41M |
Book Value | 484.84M | 506.11M | -146.15M | -132.39M | -87.8M | -76.78M |
Book Value Per Share | 8.76 | 9.16 | -2.74 | n/a | -1.67 | -2.20 |
Common Stock | 5K | 5K | n/a | n/a | n/a | n/a |
Retained Earnings | -199.03M | -174.89M | -156.56M | -141.43M | -92.83M | -80.78M |
Comprehensive Income | -745K | -241K | 42K | 16K | 124K | 208K |
Shareholders Equity | 484.84M | 506.11M | -146.15M | -132.39M | -87.8M | -76.78M |
Total Investments | 435.98M | 168M | 189M | 65.97M | 260.01M | 87.77M |
Add to Watchlist
Select watchlists to add or remove AKTS